KVV09002
Colorimetric
Plasma, Serum
Quantitative (Sandwich)
15.63 - 1,000 pg/mL
10.05 pg/mL
CV<20%
80-120%
2-8 ℃
The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.
E6, Protein E6
Generation of a spontaneous murine HPV + oral cancer model with site-specific oncogene insertion using CRISPR-SONIC., PMID:40533862
Novel biomarker discovery-coupled plasma therapy with enhanced tumor penetration for non-surgical treatment of cervical cancer., PMID:40505890
A novel Zn2+ probe for fluorescent monitoring of drug and E6/E7 protein interaction in living cells., PMID:40480729
New mouse model based on adenocarcinoma 4T1 cells expressing HPV16 E6 and E7 applied to assess the efficacy of therapeutic and prophylactic E6/E7-based HPV16 vaccines., PMID:40470197
Crosstalk Between the Oncoproteins of High-Risk Human Papillomaviruses Types 16 and 18 in Colorectal Cancer Cell Models., PMID:40468102
Boosting immune response against cervical cancer: A combined approach using oncolytic virus and targeted therapies., PMID:40403026
Human papillomavirus integration induces oncogenic host gene fusions in oropharyngeal cancers., PMID:40358390
Computational analysis of lupenone derivatives as potential inhibitor of human papillomavirus oncoprotein E6 associated cervical cancer., PMID:40316604
Thymoquinone enhances efficacy of cervical Cancer therapeutic vaccines via modulating CD8+ T cells., PMID:40316484
ZINC1797251, a novel natural product small molecule targets viral oncoprotein E6 in human papillomavirus-16 positive cervical cancer cells., PMID:40313056
Down-regulation of miR-125b by HPV16 E6 might promote cervical cancer progression through TAZ/TEAD., PMID:40303991
Ad-E6/7-HR vaccine improves the prophylactic and therapeutic efficacy in HPV-associated cancers., PMID:40268519
'Nelfinavir sensitizes a clinically relevant chemo-radioresistant cervical cancer in-vitro model by targeting the AKT-USP15/USP11-HPV16 E6/E7 axis., PMID:40242402
Evaluation of Onco E6 point of care rapid diagnostic test for human papilloma virus in Bahir Dar, Amhara Regional State, Ethiopia., PMID:40238760
Recent update on the development of HPV16 inhibitors for cervical cancer., PMID:40107437
Metformin-induced E6/E7 inhibition prevents HPV-positive cancer progression through p53 reactivation., PMID:40100964
Electrochemical Duplex Detection of E2 and E6 Genes of Human Papillomavirus Type 16 and Determination of Physical Status in High-Risk Cervical Carcinoma., PMID:40071579
Rational Design of Stapled Covalent Peptide Modifiers of Oncoprotein E6 from Human Papillomavirus., PMID:40063062
Post-treatment monitoring of surgically treated oropharyngeal squamous cell carcinoma patients using human papillomavirus cell-free DNA., PMID:40049068
[Redox Status and Protein Glutathionylation in Binase-Treated HPV16-Positive SiHa Carcinoma Cells]., PMID:39970121
Structural engineering of stabilized, expanded epitope nanoparticle vaccines for HPV., PMID:39958352
Dysregulation of G6PD by HPV E6 exacerbates cervical cancer by activating the STAT3/PLOD2 pathway., PMID:39943705
Discovering Active Chemotherapeutic Agents for Sexually Transmitted Diseases to Inhibit Pathogenic HPV-16-E6 Protein., PMID:39931987
E6AP is essential for the proliferation of HPV-positive cancer cells by preventing senescence., PMID:39919145
Molecular epidemiology of human papillomavirus variants in cervical cancer in India., PMID:39913513
Impact of screening for human papillomavirus-positive oropharyngeal cancers: a microsimulation-based modeling study., PMID:39913364
Human Papillomavirus Type 16 E6 Seroprevalence among Men Living with HIV without HPV-Driven Malignancies., PMID:39907040
Evolution of testing for the diagnosis of human papillomavirus (HPV) status in head and neck squamous cell carcinoma: Where from and where to?, PMID:39899908
The combined immunization of cervical cancer therapeutic vaccine based on Listeria balanced lethal system has a significant therapeutic effect on tumor model mice., PMID:39870008
An exploration of the natural and acquired immunological mechanisms to high-risk human papillomavirus infection and unmasking immune escape in cervical cancer: A concise synopsis., PMID:39850385
Vvax001, a Therapeutic Vaccine, for Patients with HPV16-Positive High-grade Cervical Intraepithelial Neoplasia: A Phase II Trial., PMID:39849926
Structure of E6AP in complex with HPV16-E6 and p53 reveals a novel ordered domain important for E3 ligase activation., PMID:39818213
Oncoproteins E6/E7 of the human papillomavirus types 16 & 18 synergize in modulating oncogenes and tumor suppressor proteins in colorectal cancer., PMID:39815804
DARPin-induced reactivation of p53 in HPV-positive cells., PMID:39789211
Correction: Konstantopoulos et al. HPV16 E6 Oncogene Contributes to Cancer Immune Evasion by Regulating PD-L1 Expression through a miR-143/HIF-1a Pathway. Viruses 2024, 16, 113., PMID:39772274
SLC7A11 Expression Is Up-Regulated in HPV- and Tobacco-Associated Lung Cancer., PMID:39769017
Designing of an mRNA vaccine against high-risk human papillomavirus targeting the E6 and E7 oncoproteins exploiting immunoinformatics and dynamic simulation., PMID:39761277
Characterization of the adaptive immune response in a mouse model for HPV-positive head and neck squamous cell carcinoma with implications to human disease., PMID:39751916
Comparative efficacy of HPV 16/18 DNA and E6/E7 mRNA testing in detecting high-grade cervical lesions (CIN2+) in women with cervical biopsies., PMID:39733635
[Amino Acid Substitution Patterns in the E6 and E7 Proteins of HPV Type 16: Phylogeography and Evolution]., PMID:39709561
Correlation between HPV-16 integration status and cervical intraepithelial neoplasia and cervical cancer in patients infected with HIV., PMID:39690095
Natural history of HPV-16 E6 serology among cancer-free men in a multicenter longitudinal cohort study., PMID:39658222
Amentoflavone, a biflavonoid with potential anticancer properties against viral oncoprotein E6 in Human papilloma virus-16 (HPV-16) positive cervical cancer cells., PMID:39652633
Human papillomavirus E6 alters Toll-like receptor 9 transcripts and chemotherapy responses in breast cancer cells in vitro., PMID:39644451
STING Nanoagonist Boosts Antitumor Immunity of Therapeutic DNA Vaccines., PMID:39621441
Immune Response Modulation by HPV16 Oncoproteins in Lung Cancer: Insights from Clinical and In Vitro Investigations., PMID:39599846
Genome-Wide Analysis of p53 Targets Reveals SCN2A as a Novel Player in p53-Induced Cell Arrest in HPV-Positive Cells., PMID:39599840
[A fluorescence immunochromatography method for detection of human papillomavirus type 16 E6 and L1 proteins]., PMID:39584350
ELF3 Overexpression Contributes to the Malignant Transformation of HPV16 E6/E7-Immortalized Keratinocytes by Promoting CCNE2 Expression., PMID:39572025
CAR-T cells based on a TCR mimic nanobody targeting HPV16 E6 exhibit antitumor activity against cervical cancer., PMID:39524212
Order: order@antibodysystem.com
Mail: support@antibodysystem.com
For research use only. Not for human or drug use.
Find out more about placing an order here
